Anti-Inflammatory Potential of the Selective Phosphodiesterase 4 InhibitorN-(3,5-Dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), in Human Cell Preparations-Reference-Cited by-同舟云学术

Anti-Inflammatory Potential of the Selective Phosphodiesterase 4 InhibitorN-(3,5-Dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), in Human Cell Preparations

Published:2003-11-10 Issue:2 Volume:308 Page:555-563
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Draheim Regina,Egerland Ute,Rundfeldt Chris

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Therapy of chronic obstructive pulmonary disease

2. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways

3. Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF);Expert Opinion on Investigational Drugs;2023-01-02

2. Advances in the Development of Phosphodiesterase-4 Inhibitors;Journal of Medicinal Chemistry;2020-04-07

3. Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases;Frontiers in Pharmacology;2020-03-12

4. Design and synthesis of novel indole-quinoxaline hybrids to target phosphodiesterase 4 (PDE4);Arabian Journal of Chemistry;2019-12

5. Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients;Cytokine;2019-01